Poseida Therapeutics Inc (PSTX)
3.19
-0.16
(-4.63%)
USD |
NASDAQ |
May 17, 16:00
3.19
0.00 (0.00%)
After-Hours: 20:00
Poseida Therapeutics Enterprise Value: 169.34M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 169.34M |
| May 16, 2024 | 184.37M |
| May 15, 2024 | 195.52M |
| May 14, 2024 | 143.16M |
| May 13, 2024 | 132.50M |
| May 10, 2024 | 116.50M |
| May 09, 2024 | 122.80M |
| May 08, 2024 | 122.80M |
| May 07, 2024 | 143.08M |
| May 06, 2024 | 134.35M |
| May 03, 2024 | 138.23M |
| May 02, 2024 | 130.47M |
| May 01, 2024 | 128.54M |
| April 30, 2024 | 94.61M |
| April 29, 2024 | 84.92M |
| April 26, 2024 | 66.50M |
| April 25, 2024 | 58.75M |
| April 24, 2024 | 60.69M |
| April 23, 2024 | 69.41M |
| April 22, 2024 | 68.93M |
| April 19, 2024 | 55.84M |
| April 18, 2024 | 53.90M |
| April 17, 2024 | 57.51M |
| April 16, 2024 | 56.54M |
| April 15, 2024 | 95.26M |
| Date | Value |
|---|---|
| April 12, 2024 | 124.30M |
| April 11, 2024 | 141.73M |
| April 10, 2024 | 130.11M |
| April 09, 2024 | 151.41M |
| April 08, 2024 | 147.54M |
| April 05, 2024 | 149.47M |
| April 04, 2024 | 157.21M |
| April 03, 2024 | 156.25M |
| April 02, 2024 | 140.76M |
| April 01, 2024 | 160.12M |
| March 31, 2024 | 168.83M |
| March 28, 2024 | 154.19M |
| March 27, 2024 | 143.58M |
| March 26, 2024 | 117.52M |
| March 25, 2024 | 139.72M |
| March 22, 2024 | 146.47M |
| March 21, 2024 | 139.72M |
| March 20, 2024 | 132.96M |
| March 19, 2024 | 127.17M |
| March 18, 2024 | 141.65M |
| March 15, 2024 | 157.08M |
| March 14, 2024 | 159.01M |
| March 13, 2024 | 175.42M |
| March 12, 2024 | 152.26M |
| March 11, 2024 | 175.42M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-44.83M
Minimum
Jun 29 2023
866.37M
Maximum
Jul 20 2020
209.96M
Average
198.41M
Median
Aug 03 2022
Enterprise Value Benchmarks
| Biomea Fusion Inc | 295.04M |
| Cartesian Therapeutics Inc | 366.93M |
| Lantern Pharma Inc | 26.52M |
| NovaBay Pharmaceuticals Inc | 5.156M |
| Palatin Technologies Inc | 22.26M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -24.27M |
| Revenue (Quarterly) | 28.14M |
| Total Expenses (Quarterly) | 52.72M |
| EPS Diluted (Quarterly) | -0.25 |
| Profit Margin (Quarterly) | -86.26% |
| Earnings Yield | -36.99% |
| Normalized Earnings Yield | -36.99 |